UiPath (PATH) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
Bargains could emerge as AI causes panic.
Zacks Investment Research on MSN

Is trending stock UiPath, Inc. (PATH) a buy now?

UiPath (PATH) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of ...
UiPath remains a buy, outperforming the S&P 500 with a 53.6% gain since March 2025, driven by operational turnaround. Click ...
UiPath hits an inflection point with stabilizing SaaS, AI roadmap, Maestro platform upsells, top partnerships, and clean balance sheet. See why PATH stock is a buy.
AI is now a tailwind.
Mastering Control of Time is the second main mission in Code Vein 2, and it begins just after you win your first combat ...
UiPath (NYSE: PATH), a global leader in agentic automation, today announced its UiPath Screen Agent powered by Claude Opus 4.5 achieved a No. 1 ranking on the OSWorld-Verified benchmark, an ...
UiPath’s PATH edge in today’s automation race comes down to one thing: how effectively its platform converts AI innovation ...
UiPath has a huge opportunity to become a leading AI agent orchestration platform. Cybersecurity company SentinelOne has a few growth drivers on the horizon. Both stocks are trading at very cheap ...
This week - a viral LinkedIn skirmish sparks one of diginomica's best agentic AI pieces of the year. Plus: Frugal AI sounds ...
If you've got $5,000 in your pocket, there are better ways to try to double your money than betting on sports or going to a casino. Investing in growth stocks at cheap valuations can be a much better ...